Candel Therapeutics, Inc. (CADL) stock
CADLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$5.32−0.08 (-1.48%)
Close on Nov 18, 2026Market cap $407.08MP/E –Yield –
Candel Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Candel Therapeutics
Candel Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?